Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...

D Bioprinting Market OutlookThe global 3D bioprinting market is poised to witness robust growth at a CAGR of 12–15% over the ...

AV Laboratories, a biotechnology-driven skincare brand focused on clinical longevity, today announced the appointment of Dr.

AUSTIN, TX / ACCESS Newswire / March 13, 2026 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR and FORME ...

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and ...

Global Neonatal Intensive Care Respiratory Devices Market OverviewThe global neonatal intensive care respiratory devices market is projected to grow at a compound annual growth rate of approximately 6 ...

New 2026 analysis finds Spain's national digital backbone is no longer the differentiator; autonomous communities and provider groups now compete on interoperability, cyber resilience, and hospital ...

TAMPA, FL / ACCESS Newswire / March 13, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization ...

Expanded Charitable Funding will Support Phase 1 Multiple Ascending Dose Trial and Long-Term Toxicology Studies for TIX100, a Novel Oral Therapy Targeting Beta Cell Health in Type 1 DiabetesBIRMINGHAM ...

The Calcium Phosphate Bone Cement Market is gaining significant traction worldwide as healthcare systems increasingly adopt advanced biomaterials for orthopedic and dental surgeries. Calcium phosphate ...

The global MedTech market is projected to grow at a compound annual growth rate (CAGR) of approximately 7% over the next five years. This expansion is driven by rising volumes of surgical and ...

Aplagon Announces First Patient Dosed in Phase 2a Clinical Trial of APAC in Patients with Peripheral Arterial Occlusive Disease / Chronic Limb Threatening Ischemia HELSINKI, 12 March 2026 - Aplagon, a ...